EUVIMEDEUVIMED entdecken
Crossref

Design, synthesis, and development of 4-(4-Fluorobenzyl)piperazine–acetanilide conjugates as novel tyrosinase inhibitors

Esin Akdemir Yılmaz, Suna Sabuncuoğlu, Gözde Girgin, Oya Unsal Tan

Bioorganic Chemistry · 2026

DOI: 10.1016/j.bioorg.2026.110284 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026. Verfasst von Esin Akdemir Yılmaz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey. Hauptthemen laut MEDLINE: Monophenol Monooxygenase, Enzyme Inhibitors, Drug Design, Piperazines. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Hacettepe University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of 4-(4-fluorobenzyl)piperazine derivatives (2a-u) were designed, synthesized, and evaluated as potential tyrosinase inhibitors. In vitro enzymatic assays using L-DOPA as a substrate revealed that several derivatives exhibited higher inhibitory activity than kojic acid under identical experimental conditions. Among them, compounds 2 h (4-NO2) and 2n (2-NO2) were identified as the most active derivatives, with IC50 values of 85.24 and 89.38 μM, respectively, compared with 206.42 μM for kojic acid. Structure-activity relationship analysis revealed that a short methylene linker, nitro substitution, and limited steric bulk were favorable for tyrosinase inhibition. Molecular docking studies supported these findings by demonstrating favorable interactions of the active compounds with key residues within the tyrosinase binding pocket. The biological profile of compound 2 h was further investigated through melanin content, cytotoxicity, and antioxidant activity assays. Melanin content studies revealed concentration-dependent biphasic effects on melanogenesis, while cytotoxicity assays demonstrated low toxicity toward 3 T3 cells. DPPH radical scavenging experiments indicated weak antioxidant activity for both compound 2 h and kojic acid. Overall, the combined biological, SAR, and molecular docking results identify compound 2 h as a promising lead structure for the further development of tyrosinase inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Monophenol MonooxygenaseEnzyme InhibitorsDrug DesignPiperazinesAcetanilidesStructure-Activity RelationshipMolecular Docking SimulationMolecular StructureDose-Response Relationship, DrugAnimalsMice

Stichwörter der Autor:innen

4-(4-fluorobenzyl)piperazineDPPHMelanin contentMolecular dockingTyrosinase

Substanzen

Monophenol MonooxygenaseEnzyme InhibitorsPiperazinesAcetanilides

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey.
  • Department of Toxicology, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey. Electronic address: oyaunsal@hacettepe.edu.tr.

Förderung

  • Hacettepe University

Zitieren

APA

Yılmaz, E. A., Sabuncuoğlu, S., Girgin, G., & Unsal Tan, O. (2026). Design, synthesis, and development of 4-(4-Fluorobenzyl)piperazine–acetanilide conjugates as novel tyrosinase inhibitors. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2026.110284

Vancouver

Yılmaz EA, Sabuncuoğlu S, Girgin G, Unsal Tan O. Design, synthesis, and development of 4-(4-Fluorobenzyl)piperazine–acetanilide conjugates as novel tyrosinase inhibitors. Bioorganic Chemistry. 2026. doi:10.1016/j.bioorg.2026.110284

BibTeX
@article{Ylmaz2026,
  author = {Yılmaz, Esin Akdemir and Sabuncuoğlu, Suna and Girgin, Gözde and Unsal Tan, Oya},
  title = {Design, synthesis, and development of 4-(4-Fluorobenzyl)piperazine–acetanilide conjugates as novel tyrosinase inhibitors},
  journal = {Bioorganic Chemistry},
  year = {2026},
  doi = {10.1016/j.bioorg.2026.110284}
}
Kostenlos starten →